SCHEMBL196105

SCHEMBL196105

COC(=O)c1ccc2c(C3CCCCC3)cn(Br)c2c1

nearest known ligand 0.50

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
SCN9A Q15858 5/20 0.50
SCN5A Q14524 3/20 0.50
ALDH1A1 P00352 4/20 0.44
SMN1; SMN2 Q16637 4/20 0.44
NPSR1 Q6W5P4 3/20 0.44
ATM Q13315 1/20 0.44
HPGD P15428 2/20 0.43
KDM4E B2RXH2 2/20 0.43
LMNA P02545 1/20 0.43
CYP3A4 P08684 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
RXFP1 Q9HBX9 1/20 0.43
CNR2 P34972 2/20 0.41
CNR1 P21554 1/20 0.41
NPC1 O15118 3/20 0.40
RAB9A P51151 2/20 0.40
EPHX2 P34913 1/20 0.39
USP14 P54578 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1260945 0.86 SCN9A (0.65) SCN9ASCN5AALDH1A1SMN1; SMN2NPSR1
SCHEMBL899454 0.85 SCN9A (0.64) SCN9ASCN5AALDH1A1SMN1; SMN2NPSR1
SCHEMBL27861253 0.85 SCN9A (0.48) SCN9ASCN5AALDH1A1
SCHEMBL4830054 0.81 SCN9A (0.49) SCN9ASCN5AALDH1A1SMN1; SMN2NPSR1
SCHEMBL14435340 0.79 SCN9A (0.45) SCN9ASCN5AALDH1A1NPSR1HPGD
SCHEMBL13577960 0.78 SCN9A (0.46) SCN9ASCN5AALDH1A1SMN1; SMN2NPSR1
SCHEMBL4822336 0.78 CNR2 (0.47) SCN9ASCN5AALDH1A1NPSR1HPGD
SCHEMBL4565896 0.77 SCN9A (0.43) SCN9ASCN5AALDH1A1SMN1; SMN2NPSR1
SCHEMBL4827022 0.77 SCN9A (0.46) SCN9ASCN5AALDH1A1SMN1; SMN2NPSR1
SCHEMBL772052 0.75 HRH2 (0.44) SCN9ASCN5AALDH1A1NPSR1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101443336-B Cyclopropyl fused indolobenzazepine HVC ns5b inhibitors BRISTOL MYERS SQUIBB CO 2012-07-04 CN disclosed
EP-2401280-A1 Cyclopropyl fused indolobenzazepine hcv ns5b inhibitors Bristol-Myers Squibb Company (US) 2012-01-04 EP disclosed
WO-2010099159-A1 CYCLOPROPYL FUSED INDOLOBENZAZEPINE HCV NS5B INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2010-09-02 WO disclosed